These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 1875573

  • 1. [Studies on calcium oxalate crystal formation in urolithiasis. Multi-regressive analysis of urinary CaOx crystalline volumes and the effects of urinary various substances on CaOx crystal formation].
    Kataoka K, Umekawa T, Katayama Y, Ishikawa Y, Kodama M, Takamura C, Takada M, Kato Y, Hohri K, Iguchi M.
    Nihon Hinyokika Gakkai Zasshi; 1991 May; 82(5):799-803. PubMed ID: 1875573
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Urinary magnesium and oxalic acid excretion in patients with recurrent oxalate urolithiasis.
    Takasaki E.
    Invest Urol; 1975 Jan; 12(4):251-4. PubMed ID: 1112654
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis.
    Karagülle O, Smorag U, Candir F, Gundermann G, Jonas U, Becker AJ, Gehrke A, Gutenbrunner C.
    World J Urol; 2007 Jun; 25(3):315-23. PubMed ID: 17333204
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of preincubation of seed crystals of uric acid and monosodium urate with undiluted human urine to induce precipitation of calcium oxalate in vitro : implications for urinary stone formation.
    Grover PK, Ryall RL.
    Mol Med; 2002 Sep; 8(9):525-35. PubMed ID: 12456991
    [Abstract] [Full Text] [Related]

  • 11. The composition of four-hour urine samples from patients with calcium oxalate stone disease.
    Berg C, Larsson L, Tiselius HG.
    Br J Urol; 1987 Oct; 60(4):301-6. PubMed ID: 3690199
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
    Borghi L, Meschi T, Guerra A, Bergamaschi E, Mutti A, Novarini A.
    Clin Chim Acta; 1995 Jul 31; 239(1):1-11. PubMed ID: 7586581
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Repeated urine analysis in patients with calcium stone disease.
    Bek-Jensen H, Tiselius HG.
    Eur Urol; 1998 Jul 31; 33(3):323-32. PubMed ID: 9555561
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of pH on the risk of calcium oxalate crystallization in urine.
    Berg C, Tiselius HG.
    Eur Urol; 1986 Jul 31; 12(1):59-61. PubMed ID: 3948899
    [Abstract] [Full Text] [Related]

  • 19. The effect of Phyllanthus niruri on urinary inhibitors of calcium oxalate crystallization and other factors associated with renal stone formation.
    Freitas AM, Schor N, Boim MA.
    BJU Int; 2002 Jun 31; 89(9):829-34. PubMed ID: 12010223
    [Abstract] [Full Text] [Related]

  • 20. Calcium oxalate stone formation risk - a case of disturbed relative concentrations of urinary components.
    Laube N, Rodgers A, Allie-Hamdulay S, Straub M.
    Clin Chem Lab Med; 2008 Jun 31; 46(8):1134-9. PubMed ID: 18578688
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.